Complete Filing Data
SWK Holdings Corp reported Cash And Cash Equivalents At Carrying Value of $42.76 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SWK Holdings Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.5M | $13.5M | $15.9M | $13.5M | $25.9M | $5.2M | $23.8M | $6.2M | $3.0M | $28.9M | -$7.4M | $20.8M | $12.9M | -$1.4M | -$1.1M | -$707.0K |
| Revenue * | $2.2M | $3.6M | $1.2M | $41.5M | $56.2M | $36.7M | $30.7M | $12.0K | $79.0K | $22.4M | $23.5M | $17.4M | $6.4M | $637.0K | $0.00 | $0.00 |
| General And Administrative Expense | $14.8M | $11.5M | $11.2M | $13.0M | $13.6M | $10.5M | $7.4M | $4.9M | $4.1M | $2.8M | $3.4M | $3.3M | $1.7M | $2.2M | $1.5M | $1.8M |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $14.6M | $9.5M | $33.0M | $3.7M | $16.8M | $6.2M | $24.0M | $10.4M | -$1.1M | $13.3M | $4.5M | -$1.4M | -$1.1M | -$727.0K | ||
| Income Tax Expense Benefit | $22.6M | $4.9M | -$1.3M | -$4.0M | $7.1M | -$1.5M | -$7.0M | $42.0K | $15.8M | -$21.6M | $3.3M | -$10.3M | -$9.8M | -$24.0K | -$26.0K | -$20.0K |
| Comprehensive Income Net Of Tax | $5.2M | $23.8M | $6.2M | $3.3M | $28.8M | -$7.4M | $20.8M | $12.9M | -$1.4M | |||||||
| Operating Income Loss | $20.3M | $11.6M | $14.7M | $14.1M | $4.7M | -$1.6M | -$1.5M | -$1.8M | ||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $6.2M | $8.6M | $32.0M | -$4.4M | $23.6M | $14.3M | -$1.4M | |||||||||
| Interest Expense | $1.8M | $340.0K | $374.0K | $455.0K | $338.0K | $160.0K | $381.0K | $579.0K | ||||||||
| Deferred Income Taxes And Tax Credits | $22.6M | $4.8M | -$1.3M | -$3.9M | $7.0M | -$1.7M | -$7.1M | $31.0K | $15.7M | -$21.6M | $3.3M | -$10.3M | ||||
| Research And Development Expense | $1.6M | $2.2M | $3.4M | $7.0M | $7.3M | $4.3M | $1.2M | |||||||||
| Income Loss From Equity Method Investments | $10.5M | $6.2M | $5.9M | $5.3M | $2.8M | |||||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $5.2M | $3.2M | $3.0M | $2.8M | $1.5M | |||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | $5.2M | $3.2M | $3.0M | $2.8M | $1.5M | |||||||||||
| Pharmaceutical Development Revenue | $1.2M | $5.5M | $16.1M | $5.9M | $621.0K | |||||||||||
| Revenue Not From Contract With Customer Other | $212.0K | $538.0K | $723.0K | $9.0K | $9.0K | $12.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $8.8M | $3.5M | $4.5M | $3.5M | $3.7M | $468.0K | $4.5M | $3.9M | $4.6M | $6.6M | $565.0K | $3.5M | $2.2M | $14.0M | $3.4M | $4.3M | $876.0K | -$4.7M | $4.2M | $4.3M | $6.6M | -$5.7M | $3.7M | $3.6M | $2.8M | $3.4M | $5.2M | $3.1M | -$1.0M | $3.1M | -$5.8M | -$375.0K | $2.3M | $432.0K | $1.4M | $1.5M | $620.0K | $380.0K | $60.0K | -$749.0K | -$667.0K | -$256.0K | -$296.0K | -$243.0K | -$126.0K | -$238.0K | -$283.0K |
| Revenue * | $0.00 | $1.2M | $963.0K | $628.0K | $804.0K | $279.0K | $315.0K | $9.5M | $9.4M | $13.6M | $6.9M | $11.1M | $9.6M | $22.3M | $9.4M | $10.6M | $7.9M | $7.3M | $2.0K | $1.0K | $1.0K | $2.0K | $3.0K | $5.0K | $64.0K | $6.1M | $14.9M | $4.2M | $8.6M | $5.2M | $5.7M | $5.4M | $5.8M | $3.7M | $3.4M | $3.7M | $1.6M | $1.0M | $430.0K | $54.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| General And Administrative Expense | $3.3M | $2.8M | $3.3M | $3.0M | $2.9M | $2.7M | $3.0M | $3.0M | $2.5M | $4.3M | $3.0M | $3.2M | $3.6M | $3.4M | $2.9M | $2.5M | $2.6M | $3.0M | $2.7M | $1.3M | $1.3M | $1.2M | $1.2M | $1.2M | $1.5M | $951.0K | $661.0K | $617.0K | $789.0K | $929.0K | $460.0K | $945.0K | $1.2M | $1.1M | $742.0K | $669.0K | $463.0K | $424.0K | $390.0K | $846.0K | $711.0K | $300.0K | $364.0K | $311.0K | $377.0K | $381.0K | $352.0K |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $5.4M | $1.1M | $4.1M | $5.4M | $4.5M | $8.6M | $747.0K | $4.6M | $2.8M | $17.5M | $4.3M | $3.9M | -$125.0K | -$3.4M | $3.5M | $5.0M | $7.7M | -$7.4M | $4.8M | $4.6M | $3.8M | $5.0M | $14.0M | $3.8M | $44.0K | $3.9M | -$8.1M | $303.0K | $4.6M | $1.9M | $2.6M | $3.0M | $962.0K | $601.0K | $63.0K | -$748.0K | -$666.0K | -$255.0K | -$295.0K | -$242.0K | -$125.0K | -$234.0K | -$282.0K | ||||
| Income Tax Expense Benefit | $1.9M | $1.0M | $1.3M | $906.0K | $1.0M | $229.0K | -$386.0K | $1.5M | -$109.0K | $1.9M | $182.0K | $1.1M | $513.0K | $3.5M | $939.0K | -$451.0K | -$1.0M | $1.3M | -$614.0K | $674.0K | $1.1M | -$1.7M | $1.1M | $954.0K | $1.1M | $1.4M | $3.7M | -$3.1M | $1.5M | $500.0K | $592.0K | $706.0K | $13.0K | $7.0K | $3.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $4.0K | $1.0K | ||||
| Comprehensive Income Net Of Tax | $4.3M | $876.0K | -$4.7M | $4.2M | $4.3M | $6.6M | -$5.7M | $3.7M | $3.6M | $1.9M | $3.3M | $7.1M | $3.1M | -$1.1M | $3.1M | -$5.9M | -$375.0K | $2.3M | $432.0K | $1.4M | $2.3M | $620.0K | $380.0K | $60.0K | -$749.0K | -$667.0K | |||||||||||||||||||||
| Operating Income Loss | $6.7M | $4.6M | $8.1M | $4.1M | $901.0K | $1.1M | $4.3M | $6.8M | $1.7M | $5.3M | $2.6M | $16.6M | $3.1M | $2.6M | $2.6M | $3.0M | $1.1M | $586.0K | $40.0K | -$792.0K | -$711.0K | -$300.0K | -$364.0K | -$311.0K | -$377.0K | -$381.0K | -$352.0K | ||||||||||||||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$5.7M | $3.7M | $3.6M | $1.9M | $3.5M | $12.1M | $3.8M | -$25.0K | $4.0M | -$5.1M | $303.0K | $3.1M | $1.4M | $2.0M | $1.5M | $949.0K | $594.0K | $60.0K | -$749.0K | -$667.0K | |||||||||||||||||||||||||||
| Interest Expense | $1.1M | $1.3M | $176.0K | $363.0K | $182.0K | $82.0K | $80.0K | $80.0K | $53.0K | $94.0K | $145.0K | $101.0K | $163.0K | $101.0K | $79.0K | $78.0K | $102.0K | $79.0K | $2.0K | $381.0K | $141.0K | $223.0K | |||||||||||||||||||||||||
| Deferred Income Taxes And Tax Credits | $1.3M | $229.0K | -$122.0K | $1.1M | $918.0K | $1.3M | $1.1M | $954.0K | $3.7M | $1.5M | |||||||||||||||||||||||||||||||||||||
| Research And Development Expense | $147.0K | $645.0K | $758.0K | $585.0K | $520.0K | $530.0K | $606.0K | $1.5M | $719.0K | $1.8M | $1.5M | $1.9M | $2.5M | $1.5M | $1.5M | $1.2M | $1.0M | $1.2M | $286.0K | ||||||||||||||||||||||||||||
| Income Loss From Equity Method Investments | $335.0K | $10.2M | $1.3M | $2.1M | $1.7M | $1.6M | $1.3M | $1.6M | $1.8M | $1.2M | $1.5M | $627.0K | $414.0K | ||||||||||||||||||||||||||||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $171.0K | $5.0M | $656.0K | $1.1M | $842.0K | $822.0K | $678.0K | $811.0K | $944.0K | $633.0K | $801.0K | $329.0K | $214.0K | ||||||||||||||||||||||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | $171.0K | $5.0M | $656.0K | $1.1M | $842.0K | $822.0K | $678.0K | $811.0K | $944.0K | $633.0K | $801.0K | $329.0K | $214.0K | ||||||||||||||||||||||||||||||||||
| Pharmaceutical Development Revenue | $804.0K | $279.0K | $183.0K | $118.0K | $5.1M | $114.0K | $236.0K | $187.0K | $10.5M | $198.0K | $2.8M | $150.0K | $148.0K | $149.0K | |||||||||||||||||||||||||||||||||
| Revenue Not From Contract With Customer Other | $57.0K | $46.0K | $39.0K | $36.0K | $33.0K | $1.0K | $480.0K | $496.0K | $20.0K | $18.0K | $2.0K | $1.0K | $1.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $235.1M | $288.7M | $280.3M | $279.9M | $267.2M | $240.5M | $236.5M | $213.1M | $208.0M | $204.3M | $175.1M | $182.1M | $50.3M | $37.2M | $38.0M | $39.0M | |
| Cash And Cash Equivalents At Carrying Value | $42.8M | $5.9M | $4.5M | $6.2M | $3.0M | $11.2M | $20.2M | $30.6M | $32.2M | $47.3M | $58.7M | $7.7M | $24.6M | $38.2M | $39.3M | $38.6M | |
| Interest And Fee Income Loans And Leases | $38.4M | $40.8M | $36.3M | $35.5M | $39.3M | $30.8M | $30.1M | $26.0M | $26.9M | $15.7M | $17.3M | $11.5M | $3.1M | $497.0K | |||
| Retained Earnings Accumulated Deficit | -$4.18B | -$4.13B | -$4.14B | -$4.15B | -$4.16B | -$4.19B | -$4.20B | -$4.22B | -$4.23B | -$4.23B | -$4.26B | -$4.25B | -$4.27B | -$4.28B | -$4.28B | -$4.28B | |
| Assets | $272.4M | $332.2M | $334.3M | $299.6M | $282.7M | $273.9M | $254.4M | $215.7M | $209.9M | $208.9M | $180.5M | $188.2M | $61.6M | $45.3M | $38.3M | $39.3M | |
| Liabilities And Stockholders Equity | $272.4M | $332.2M | $334.3M | $299.6M | $282.7M | $273.9M | $254.4M | $215.7M | $209.9M | $208.9M | $180.5M | $188.2M | $61.6M | $45.3M | $38.3M | $39.3M | |
| Liabilities | $37.3M | $43.5M | $53.9M | $19.7M | $15.4M | $33.4M | $17.8M | $2.6M | $1.9M | $871.0K | $1.0M | $1.3M | $5.7M | $1.1M | $250.0K | $320.0K | |
| Common Stock Value | $12.0K | $12.0K | $12.0K | $12.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $43.0K | $43.0K | $42.0K | $42.0K | |
| Accounts Payable And Accrued Liabilities Current | $5.0M | $2.8M | $3.9M | $3.9M | $5.1M | $3.7M | $3.1M | $2.6M | $1.8M | $682.0K | $788.0K | $864.0K | $363.0K | $91.0K | $187.0K | $201.0K | |
| Amortization Of Deferred Loan Origination Fees Net | $2.2M | $3.9M | $3.8M | $2.2M | $1.1M | $2.0M | $349.0K | -$487.0K | $1.9M | $3.1M | $1.8M | $448.0K | $702.0K | ||||
| Notes And Loans Receivable Net Current | $236.6M | $181.6M | $204.5M | $172.8M | $166.6M | $152.0M | $126.4M | $99.3M | $93.3M | $660.0K | $230.0K | ||||||
| Warrant Assets | $5.9M | $4.4M | $1.8M | $1.2M | $3.4M | $3.0M | $3.6M | $2.8M | $987.0K | $1.0M | $1.9M | $679.0K | |||||
| Cash And Cash Equivalents Period Increase Decrease | -$8.2M | -$9.1M | -$10.3M | -$1.6M | -$15.1M | -$11.4M | $51.1M | -$16.9M | -$13.6M | -$1.1M | $651.0K | ||||||
| Liabilities Current | $5.0M | $5.6M | $3.9M | $6.3M | $5.1M | $15.4M | $3.1M | $2.6M | $863.0K | $363.0K | $91.0K | $187.0K | $231.0K | ||||
| Assets Current | $46.8M | $20.3M | $11.9M | $10.4M | $47.4M | $6.7M | $16.3M | $22.6M | $71.1M | $9.0M | $26.0M | $38.3M | $39.3M | ||||
| Accounts Receivable Net | $3.9M | $5.8M | $4.7M | $3.1M | $1.8M | $1.9M | $2.6M | $2.2M | $1.6M | $1.1M | $1.1M | $1.1M | |||||
| Marketable Securities | $1.0M | $1.2M | $1.8M | $1.9M | $2.6M | $5.3M | $4.8M | $3.1M | |||||||||
| Property Plant And Equipment Net | $5.4M | $5.8M | $5.8M | $5.2M | $1.3M | $25.0K | $5.0K | $3.0K | $4.0K | $6.0K | |||||||
| Prepaid Expense And Other Assets | $640.0K | $474.0K | $126.0K | $240.0K | $720.0K | $32.0K | $63.0K | ||||||||||
| Other Liabilities Noncurrent | $240.0K | $335.0K | $2.0M | $2.1M | $1.8M | $1.1M | $203.0K | $11.0K | $1.0M | ||||||||
| Other Assets Noncurrent | $0.00 | $3.0M | $3.1M | $1.7M | $2.0M | $1.5M | $692.0K | $211.0K | |||||||||
| Marketable Securities Unrealized Gain Loss | -$528.0K | $1.8M | -$591.0K | $1.6M | -$1.0M | ||||||||||||
| Proceeds Repayment Of Finance Receivables | $11.7M | $45.7M | $67.2M | $11.8M | $44.0M | $61.7M | $7.4M | $45.3M | |||||||||
| Other Assets Current | $163.0K | $2.1M | $1.9M | $1.1M | $1.7M | $542.0K | $783.0K | $138.0K | |||||||||
| Equity Method Investments | $7.0M | $8.0M | $9.0M | $10.4M | $13.0M | ||||||||||||
| Minority Interest | $3.8M | $4.3M | $4.9M | $5.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $254.2M | $246.5M | $292.7M | $283.4M | $282.8M | $279.9M | $277.6M | $273.9M | $274.4M | $277.4M | $271.5M | $270.8M | $260.7M | $258.2M | $244.1M | $235.7M | $232.1M | $232.0M | $227.6M | $223.3M | $219.0M | $213.1M | $209.7M | $215.4M | $211.7M | $208.0M | $216.8M | $214.8M | $211.4M | $180.5M | $177.3M | $178.4M | $178.6M | $184.3M | $184.5M | $128.8M | $53.3M | $51.8M | $38.5M | $37.8M | $37.3M | $36.9M | $37.2M | $37.8M | $38.4M | $38.7M | |||||||||
| Cash And Cash Equivalents At Carrying Value | $10.2M | $8.0M | $29.8M | $17.2M | $5.5M | $5.5M | $31.0M | $6.8M | $3.2M | $19.4M | $55.1M | $41.4M | $42.9M | $18.6M | $6.6M | $1.6M | $9.3M | $17.2M | $24.3M | $4.5M | $27.4M | $39.2M | $19.2M | $21.3M | $21.5M | $16.0M | $36.4M | $40.5M | $66.4M | $76.6M | $61.2M | $24.8M | $28.4M | $59.5M | $69.2M | $15.8M | $3.9M | $9.9M | $17.8M | $24.7M | $37.0M | $37.6M | $37.9M | $38.6M | $38.8M | $39.0M | $39.0M | $39.2M | |||||||
| Interest And Fee Income Loans And Leases | $10.8M | $8.5M | $10.7M | $9.5M | $10.0M | $11.0M | $8.6M | $9.3M | $9.3M | $8.5M | $6.8M | $10.4M | $9.4M | $11.8M | $8.7M | $7.9M | $7.7M | $7.1M | $6.2M | $5.7M | $9.4M | $5.9M | $6.8M | $6.8M | $5.4M | $5.7M | $4.7M | $2.8M | $6.5M | $3.5M | $4.0M | $4.0M | $4.1M | $1.9M | $2.0M | $2.0M | $811.0K | $553.0K | $374.0K | ||||||||||||||||
| Retained Earnings Accumulated Deficit | -$4.16B | -$4.17B | -$4.13B | -$4.14B | -$4.14B | -$4.14B | -$4.15B | -$4.15B | -$4.16B | -$4.15B | -$4.16B | -$4.16B | -$4.17B | -$4.17B | -$4.19B | -$4.20B | -$4.20B | -$4.20B | -$4.20B | -$4.21B | -$4.21B | -$4.22B | -$4.22B | -$4.22B | -$4.22B | -$4.22B | -$4.22B | -$4.25B | -$4.26B | -$4.25B | -$4.25B | -$4.25B | -$4.25B | -$4.27B | -$4.27B | -$4.27B | -$4.28B | -$4.28B | -$4.28B | -$4.28B | -$4.28B | -$4.28B | -$4.28B | -$4.28B | |||||||||||
| Assets | $289.4M | $285.7M | $331.3M | $321.3M | $321.0M | $322.0M | $315.8M | $290.4M | $300.7M | $292.3M | $284.4M | $286.0M | $276.6M | $272.8M | $277.2M | $256.8M | $259.0M | $265.1M | $247.5M | $224.7M | $221.3M | $213.1M | $217.3M | $214.2M | $218.5M | $215.6M | $212.4M | $185.2M | $182.2M | $183.8M | $184.3M | $190.4M | $191.3M | $135.1M | $71.4M | $69.3M | $45.5M | $44.9M | $45.3M | $37.1M | $37.7M | $38.0M | $38.6M | $38.9M | |||||||||||
| Liabilities And Stockholders Equity | $289.4M | $285.7M | $331.3M | $321.3M | $321.4M | $322.4M | $315.8M | $290.4M | $300.7M | $292.3M | $284.4M | $286.0M | $276.6M | $272.8M | $277.2M | $256.8M | $259.0M | $265.1M | $247.5M | $224.7M | $221.3M | $213.1M | $217.3M | $214.2M | $218.5M | $215.6M | $212.4M | $185.2M | $182.2M | $183.8M | $184.3M | $190.4M | $191.3M | $135.1M | $71.4M | $69.3M | $45.5M | $44.9M | $45.3M | $37.1M | $37.7M | $38.0M | $38.6M | $38.9M | |||||||||||
| Liabilities | $35.2M | $39.2M | $38.6M | $37.8M | $38.2M | $42.1M | $38.3M | $16.6M | $26.4M | $14.8M | $12.9M | $15.2M | $16.0M | $14.6M | $33.1M | $21.1M | $26.9M | $33.1M | $19.9M | $1.3M | $2.3M | $3.4M | $1.9M | $2.5M | $1.7M | $792.0K | $917.0K | $754.0K | $908.0K | $1.3M | $1.3M | $1.5M | $2.1M | $1.2M | $12.9M | $12.1M | $1.3M | $828.0K | $962.0K | $203.0K | $479.0K | $153.0K | $169.0K | $179.0K | |||||||||||
| Common Stock Value | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $131.0K | $131.0K | $99.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | $42.0K | $42.0K | $42.0K | $42.0K | |||||||||||
| Accounts Payable And Accrued Liabilities Current | $2.9M | $2.1M | $2.0M | $2.9M | $3.3M | $4.4M | $2.8M | $3.0M | $1.8M | $4.7M | $2.8M | $4.9M | $4.5M | $3.1M | $4.0M | $3.6M | $2.9M | $4.1M | $3.5M | $1.3M | $2.3M | $3.4M | $1.5M | $2.5M | $1.5M | $591.0K | $730.0K | $593.0K | $719.0K | $1.1M | $826.0K | $914.0K | $1.5M | $694.0K | $1.6M | $809.0K | $352.0K | $143.0K | $168.0K | $137.0K | $414.0K | $89.0K | $76.0K | $85.0K | |||||||||||
| Amortization Of Deferred Loan Origination Fees Net | $1.5M | $837.0K | $1.5M | $421.0K | $628.0K | $536.0K | $600.0K | $837.0K | $568.0K | $908.0K | $344.0K | $72.0K | |||||||||||||||||||||||||||||||||||||||||||
| Notes And Loans Receivable Net Current | $265.5M | $261.3M | $274.5M | $223.6M | $223.0M | $237.0M | $213.0M | $174.9M | $188.3M | $196.1M | $203.0M | $209.9M | $183.2M | $178.4M | $178.0M | $175.0M | $169.2M | $154.4M | $165.6M | $170.7M | $165.8M | $163.7M | $139.2M | $130.8M | $88.5M | $74.7M | $89.5M | $122.9M | $122.4M | $95.5M | $961.0K | $885.0K | $957.0K | $667.0K | $295.0K | $230.0K | |||||||||||||||||||
| Warrant Assets | $7.6M | $4.6M | $4.2M | $2.0M | $835.0K | $610.0K | $1.3M | $1.5M | $683.0K | $5.1M | $2.5M | $2.9M | $3.7M | $3.9M | $3.3M | $2.4M | $2.3M | $1.7M | $2.9M | $4.0M | $3.1M | $2.1M | $1.3M | $1.5M | $1.4M | $841.0K | $539.0K | $1.3M | $866.0K | $1.8M | $2.1M | $4.2M | $1.4M | ||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$1.4M | $13.2M | $19.0M | -$9.1M | $8.3M | $13.9M | $759.0K | -$3.8M | $164.0K | -$301.0K | -$211.0K | ||||||||||||||||||||||||||||||||||||||||||||
| Liabilities Current | $2.9M | $6.7M | $6.7M | $5.0M | $5.5M | $4.4M | $24.8M | $3.0M | $12.3M | $4.7M | $2.8M | $4.9M | $4.5M | $3.1M | $15.2M | $3.6M | $9.4M | $18.4M | $694.0K | $1.6M | $809.0K | $352.0K | $143.0K | $168.0K | $137.0K | $414.0K | $89.0K | $76.0K | $87.0K | ||||||||||||||||||||||||||
| Assets Current | $16.3M | $21.2M | $75.9M | $25.2M | $14.8M | $13.9M | $37.2M | $13.1M | $8.9M | $28.5M | $58.8M | $46.0M | $24.8M | $12.8M | $6.9M | $17.0M | $22.7M | $28.8M | $71.5M | $18.3M | $5.6M | $11.5M | $18.9M | $25.9M | $37.1M | $37.7M | $38.0M | $38.6M | $38.9M | ||||||||||||||||||||||||||
| Accounts Receivable Net | $5.6M | $5.6M | $4.7M | $6.4M | $7.4M | $6.4M | $4.4M | $4.4M | $4.3M | $7.4M | $1.9M | $2.0M | $2.3M | $2.6M | $2.2M | $4.6M | $2.0M | $2.0M | $2.5M | $2.2M | $1.9M | $1.9M | $1.6M | $1.6M | $1.6M | $1.4M | $1.1M | $884.0K | $1.4M | $1.3M | $1.5M | $1.8M | $1.1M | ||||||||||||||||||||||
| Marketable Securities | $500.0K | $487.0K | $1.0M | $2.8M | $2.4M | $2.1M | $1.1M | $1.3M | $912.0K | $1.9M | $498.0K | $511.0K | $532.0K | $1.2M | $1.2M | $1.7M | $3.3M | $4.2M | $4.3M | $3.5M | $3.7M | $5.1M | $2.9M | $6.3M | $6.3M | $4.8M | $3.1M | $3.1M | $3.0M | ||||||||||||||||||||||||||
| Property Plant And Equipment Net | $28.0K | $48.0K | $4.8M | $5.0M | $5.2M | $5.5M | $5.6M | $5.6M | $5.9M | $6.1M | $6.0M | $5.8M | $5.7M | $5.5M | $3.4M | $2.6M | $1.3M | $1.3M | $5.0K | $6.0K | $6.0K | $3.0K | $4.0K | $4.0K | $5.0K | $5.0K | |||||||||||||||||||||||||||||
| Prepaid Expense And Other Assets | $1.2M | $1.3M | $190.0K | $242.0K | $290.0K | $1.5M | $570.0K | $645.0K | $858.0K | $659.0K | $314.0K | $169.0K | $212.0K | $258.0K | $497.0K | $645.0K | $394.0K | $118.0K | $149.0K | $168.0K | $19.0K | $32.0K | $48.0K | $66.0K | $19.0K | $40.0K | |||||||||||||||||||||||||||||
| Other Liabilities Noncurrent | $361.0K | $519.0K | $309.0K | $1.6M | $1.6M | $1.9M | $2.3M | $2.4M | $2.8M | $1.5M | $1.6M | $1.8M | $779.0K | $843.0K | $1.0M | $1.0M | $1.2M | $137.0K | $607.0K | $634.0K | $750.0K | ||||||||||||||||||||||||||||||||||
| Other Assets Noncurrent | $432.0K | $466.0K | $2.6M | $3.4M | $4.5M | $3.9M | $4.1M | $3.1M | $2.4M | $1.8M | $1.9M | $1.9M | $1.0M | $1.1M | $619.0K | $705.0K | $422.0K | $267.0K | $147.0K | $115.0K | $2.0K | ||||||||||||||||||||||||||||||||||
| Marketable Securities Unrealized Gain Loss | $0.00 | -$6.0K | -$143.0K | $0.00 | $13.0K | -$519.0K | -$28.0K | $342.0K | $283.0K | $932.0K | -$178.0K | $402.0K | -$890.0K | $1.8M | $100.0K | -$541.0K | -$124.0K | ||||||||||||||||||||||||||||||||||||||
| Proceeds Repayment Of Finance Receivables | $9.4M | $1.9M | $17.0M | $2.3M | $1.3M | $23.9M | $14.9M | $225.0K | $14.2M | ||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets Current | $543.0K | $1.1M | $1.1M | $1.6M | $1.9M | $2.1M | $1.8M | $1.9M | $1.3M | $1.2M | $1.4M | $1.6M | $1.1M | $1.1M | $984.0K | $1.9M | $2.2M | $1.5M | |||||||||||||||||||||||||||||||||||||
| Equity Method Investments | $7.2M | $7.5M | $7.7M | $8.2M | $8.5M | $8.7M | $9.3M | $9.7M | $10.0M | $10.6M | $11.8M | $13.0M | |||||||||||||||||||||||||||||||||||||||||||
| Minority Interest | $3.9M | $4.0M | $4.2M | $4.4M | $4.6M | $4.7M | $5.0M | $5.2M | $5.4M | $5.7M | $6.3M | $7.0M | $7.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $1.2M | $944.0K | $509.0K | $500.0K | $1.2M | $728.0K | $530.0K | $267.0K | $300.0K | $363.0K | $640.0K | $844.0K | $254.0K | $586.0K | $81.0K | $8.0K |
| Net Cash Provided By Used In Operating Activities | $27.3M | $23.0M | $14.9M | $8.2M | $34.3M | $19.3M | $18.5M | $19.6M | $19.5M | $9.6M | $11.2M | $5.1M | $1.3M | -$1.1M | -$1.2M | -$1.3M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.6M | -$1.3M | $371.0K | -$1.6M | $2.2M | $1.5M | $1.7M | -$1.3M | $1.2M | -$106.0K | -$76.0K | $498.0K | $234.0K | -$94.0K | -$14.0K | $201.0K |
| Net Cash Provided By Used In Investing Activities | $68.1M | -$10.1M | -$48.9M | -$43.5M | $25.8M | -$35.2M | -$26.7M | -$28.1M | -$12.1M | -$21.1M | -$18.9M | -$55.6M | -$20.1M | -$19.5M | $169.0K | $1.9M |
| Net Cash Provided By Used In Financing Activities | -$58.5M | -$12.2M | $33.1M | -$1.4M | -$20.2M | $7.7M | -$883.0K | -$1.8M | -$9.0M | -$3.7M | -$3.8M | $101.6M | $1.8M | $7.0M | $22.0K | |
| Payments To Acquire Finance Receivables | $28.5M | $63.7M | $74.1M | $93.1M | $42.4M | $42.9M | $51.0M | $90.1M | $37.4M | $75.0M | -$10.3M | -$7.2M | $6.5M | |||
| Payments To Acquire Property Plant And Equipment | $512.0K | $138.0K | $496.0K | $297.0K | $1.1M | $3.9M | $48.0K | $50.0K | $1.0K | $4.0K | $4.0K | $6.0K | ||||
| Increase Decrease In Other Operating Assets | -$1.3M | -$199.0K | $787.0K | $44.0K | $1.8M | $959.0K | $205.0K | -$202.0K | $42.0K | $396.0K | $648.0K | $12.0K | ||||
| Increase Decrease In Accounts Receivable | $558.0K | $583.0K | $59.0K | $74.0K | $525.0K | $331.0K | $197.0K | |||||||||
| Depreciation Depletion And Amortization | $40.0K | $1.4M | $2.6M | $2.6M | $4.1M | $12.1M | $5.0M | $2.0K | $5.0K | $2.0K | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$19.0K | -$30.0K | $3.0K | $35.0K | ||||||||||||
| Payments To Minority Shareholders | $9.0M | $3.7M | $3.6M | $3.6M | $2.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $307.0K | $249.0K | $111.0K | $170.0K | $164.0K | $35.0K | $59.0K | $166.0K | $85.0K | $192.0K | $187.0K | $177.0K | $179.0K | $183.0K | $187.0K | $147.0K | $88.0K | $102.0K | $56.0K | $61.0K | $79.0K | $78.0K | $106.0K | $197.0K | $617.0K | $62.0K | $76.0K | $71.0K | $72.0K | $60.0K | $410.0K | $73.0K | $34.0K | $23.0K | $21.0K | |||
| Net Cash Provided By Used In Operating Activities | $8.3M | $4.4M | $664.0K | $4.3M | $4.4M | $3.3M | $7.0M | $5.2M | $3.0M | $2.3M | $3.4M | $1.3M | $168.0K | -$301.0K | -$378.0K | |||||||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$872.0K | -$1.2M | -$1.4M | -$270.0K | $350.0K | $994.0K | -$291.0K | $610.0K | $48.0K | $298.0K | $681.0K | $443.0K | $77.0K | -$98.0K | -$116.0K | |||||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | $22.7M | $9.2M | -$11.1M | -$5.8M | -$5.2M | -$4.4M | $12.7M | -$14.3M | $14.1M | $12.6M | -$1.6M | -$10.0M | -$4.0K | $167.0K | ||||||||||||||||||||||||
| Net Cash Provided By Used In Financing Activities | -$7.1M | -$13.3M | $7.5M | -$8.0K | -$600.0K | $14.2M | -$745.0K | -$8.8M | -$977.0K | -$984.0K | $4.9M | |||||||||||||||||||||||||||
| Payments To Acquire Finance Receivables | $10.0M | $446.0K | $13.0M | $22.7M | $7.1M | $5.5M | $11.2M | $29.3M | $3.6M | $3.5M | $12.0M | |||||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $100.0K | $0.00 | $8.0K | $58.0K | $321.0K | $3.0K | $3.0K | $50.0K | $4.0K | |||||||||||||||||||||||||||||
| Increase Decrease In Other Operating Assets | -$980.0K | $283.0K | $915.0K | $225.0K | $308.0K | $462.0K | $9.0K | $189.0K | $112.0K | -$327.0K | $87.0K | |||||||||||||||||||||||||||
| Increase Decrease In Accounts Receivable | $543.0K | $265.0K | -$58.0K | $88.0K | $145.0K | $86.0K | -$172.0K | -$105.0K | ||||||||||||||||||||||||||||||
| Depreciation Depletion And Amortization | $2.0K | $19.0K | $19.0K | $234.0K | $421.0K | $514.0K | $652.0K | $648.0K | $704.0K | $1.7M | $3.5M | $1.0K | ||||||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $87.0K | $273.0K | $138.0K | -$18.0K | $30.0K | |||||||||||||||||||||||||||||||||
| Payments To Minority Shareholders | $8.8M | $977.0K | $974.0K | $1.1M | $329.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.21 | $1.09 | $1.25 | $1.05 | $2.02 | $0.40 | $1.85 | $0.47 | $0.23 | $2.22 | -$0.57 | $3.20 | $0.31 | -$0.03 | -$0.03 | -$0.02 |
| Weighted Average Number Of Diluted Shares Outstanding | 12.2M | 12.4M | 12.7M | 12.9M | 12.8M | 12.9M | 12.9M | 13.1M | 13.0M | 13.0M | 13.0K | 6.5K | 41.4K | 41.2M | 41.2M | 41.2M |
| Earnings Per Share Basic | $-0.21 | $1.09 | $1.26 | $1.05 | $2.03 | $0.40 | $1.85 | $0.47 | $0.23 | $2.22 | $-0.57 | $3.20 | $0.31 | $-0.03 | ||
| Weighted Average Number Of Shares Outstanding Basic | 12.2M | 12.4M | 12.7M | 12.8M | 12.8M | 12.9M | 12.9M | 13.1M | 13.0M | 13.0M | 13.0K | 6.5K | 41.3K | 41.2M | 41.2M | 41.2M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 12.1M | 12.2M | 12.5M | 12.8M | 12.8M | 12.8M | 12.9M | 12.9M | 13.1M | 13.1M | 13.1M | 13.1M | 43.0M | 42.9M | 41.6M | 41.6M |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 25.0M | 250.0M | 250.0M | 250.0M | 250.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 12.1M | 12.2M | 12.5M | 12.8M | 12.8M | 12.9M | 12.9M | 13.1M | 13.1M | 13.1M | 13.1M | 43.0M | 42.9M | 41.6M | 41.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.72 | $0.29 | $0.37 | $0.28 | $0.30 | $0.04 | $0.36 | $0.31 | $0.36 | $0.51 | $0.04 | $0.27 | $0.17 | $1.09 | $0.17 | $0.34 | $0.07 | -$0.36 | $0.32 | $0.34 | $0.51 | -$0.44 | $0.28 | $0.28 | $0.21 | $0.26 | $0.40 | $0.24 | -$0.08 | $0.24 | -$0.44 | -$0.03 | $0.17 | $0.06 | $0.03 | $0.04 | $0.01 | $0.01 | $0.00 | -$0.02 | -$0.02 | -$0.01 | -$0.01 | -$0.01 | $0.00 | -$0.01 | -$0.01 | |
| Weighted Average Number Of Diluted Shares Outstanding | 12.1M | 12.2M | 12.2M | 12.4M | 12.5M | 12.5M | 12.6M | 12.8M | 12.9M | 12.9M | 12.9M | 12.9M | 12.9M | 12.8M | 12.9M | 12.9M | 12.9M | 12.9K | 12.9M | 12.9M | 12.9M | 13.1M | 13.1M | 13.1M | 13.0M | 13.0M | 13.1M | 13.1M | 13.1K | 13.1M | 13.0K | 13.0K | 13.0K | 6.8K | 41.6M | 41.5M | 41.5M | 41.4M | 41.4M | 41.2M | 41.2M | 41.2M | 41.2M | 41.2M | 41.2M | 41.2M | ||
| Earnings Per Share Basic | $0.72 | $0.29 | $0.37 | $0.28 | $0.30 | $0.04 | $0.36 | $0.31 | $0.36 | $0.52 | $0.04 | $0.27 | $0.18 | $1.09 | $0.18 | $0.34 | $0.07 | $-0.36 | $0.32 | $0.34 | $0.51 | $-0.44 | $0.28 | $0.28 | $0.21 | $0.26 | $0.40 | $0.24 | $-0.08 | $0.24 | $-0.44 | $-0.03 | $0.17 | $0.06 | $0.03 | $0.04 | $0.01 | $0.01 | $0.00 | $-0.02 | $-0.02 | $-0.01 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 12.1M | 12.2M | 12.2M | 12.3M | 12.5M | 12.5M | 12.5M | 12.7M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.9M | 12.9M | 12.9K | 12.9M | 12.9M | 12.9M | 13.1M | 13.1M | 13.1M | 13.0M | 13.0M | 13.1M | 13.1M | 13.1K | 13.1M | 13.0K | 13.0K | 13.0K | 6.7K | 41.5M | 41.5M | 41.4M | 41.4M | 41.3M | 41.2M | 41.2M | 41.2M | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 12.1M | 12.2M | 12.2M | 12.3M | 12.4M | 12.5M | 12.5M | 12.6M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.9M | 12.9M | 12.9M | 12.9M | 13.1M | 13.1M | 13.1M | 13.2M | 13.0M | 13.2M | 13.1M | 13.1M | 13.1M | 13.1M | 131.2M | 131.1M | 99.1M | 43.2M | 43.2M | 43.0M | 43.0M | 43.0M | 42.9M | 44.4M | 41.8M | 41.6M | 41.6M | ||||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 25.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Issued | 12.1M | 12.2M | 12.2M | 12.3M | 12.4M | 12.5M | 12.5M | 12.6M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M | 12.9M | 12.9M | 12.9M | 12.9M | 13.1M | 13.1M | 13.1M | 13.2M | 13.0M | 13.2M | 13.1M | 13.1M | 13.1M | 13.1M | 131.2M | 131.1M | 99.1M | 43.2M | 43.2M | 43.0M | 43.0M | 43.0M | 42.9M | 44.4M | 41.8M | 41.6M | 41.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | -$14.7M | -$10.0M | -$31.0M | $31.9M | $16.1M | $19.1M | $12.6M | $12.6M | $21.2M | $3.9M | $1.7M | $2.2M | $1.5M | $1.8M | ||
| Additional Paid In Capital | $4.42B | $4.42B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.32B | $4.32B | $4.32B | $4.32B |
| Unrealized Gain Loss On Derivatives | $775.0K | $2.4M | -$55.0K | $417.0K | $272.0K | -$586.0K | $362.0K | $484.0K | -$1.1M | $588.0K | -$3.3M | -$245.0K | ||||
| Fair Value Adjustment Of Warrants | -$775.0K | -$2.4M | $55.0K | -$417.0K | -$272.0K | $586.0K | -$362.0K | -$484.0K | $1.1M | -$588.0K | $3.3M | $245.0K | -$60.0K | |||
| Depreciation And Amortization | $2.6M | $2.6M | $4.1M | $12.1M | $5.0M | $17.0K | $10.0K | $3.0K | $2.0K | |||||||
| Paid In Kind Interest | $1.8M | $6.0M | $950.0K | $2.1M | $1.3M | $191.0K | $1.8M | $398.0K | $1.1M | -$3.6M | -$119.0K | |||||
| Amortization Of Financing Costs | $1.4M | $1.1M | $493.0K | $69.0K | $49.0K | $188.0K | $188.0K | $300.0K | $363.0K | $381.0K | $143.0K | $47.0K | ||||
| Stock Repurchased During Period Value | $3.1M | $6.0M | $6.3M | $1.1M | $2.0M | $883.0K | $1.4M | |||||||||
| Warrants And Rights Outstanding | $76.0K | $13.0K | $91.0K | $189.0K | $259.0K | $421.0K | $292.0K | |||||||||
| Marketable Investment Principal Payment | $28.0K | $43.0K | $122.0K | $62.0K | $66.0K | $69.0K | $93.0K | $41.0K | $80.0K | |||||||
| Interest And Other Income | -$824.0K | -$209.0K | $158.0K | $284.0K | $530.0K | |||||||||||
| Investment Income Interest | $92.0K | $266.0K | $360.0K | $166.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | -$1.6M | -$1.5M | -$4.3M | -$4.7M | -$5.3M | -$6.8M | -$1.7M | -$5.3M | $6.9M | $5.7M | $6.3M | $6.7M | $9.1M | $8.0M | $3.4M | $1.4M | $2.0M | $14.1M | $1.2M | $2.4M | $1.5M | $951.0K | $661.0K | $931.0K | $9.0M | $1.3M | $11.8M | $3.5M | $1.6M | $1.3M | $965.0K | $669.0K | $463.0K | $424.0K | $390.0K | $846.0K | $711.0K | $300.0K | $364.0K | $311.0K | $377.0K | $381.0K | $352.0K | ||||
| Additional Paid In Capital | $4.42B | $4.42B | $4.42B | $4.42B | $4.42B | $4.42B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.43B | $4.40B | $4.32B | $4.32B | $4.32B | $4.32B | $4.32B | $4.32B | $4.32B | $4.32B | $4.32B | $4.32B | |||
| Unrealized Gain Loss On Derivatives | $2.6M | $347.0K | -$424.0K | $47.0K | $226.0K | -$95.0K | -$162.0K | $399.0K | -$982.0K | $1.8M | -$472.0K | -$693.0K | -$214.0K | $609.0K | $283.0K | $87.0K | $622.0K | -$1.9M | -$1.2M | $748.0K | $258.0K | $819.0K | -$238.0K | $300.0K | -$191.0K | -$143.0K | -$472.0K | $496.0K | $471.0K | -$30.0K | -$2.0M | -$1.6M | $371.0K | -$570.0K | $219.0K | ||||||||||||
| Fair Value Adjustment Of Warrants | $424.0K | $95.0K | $982.0K | $693.0K | -$283.0K | $1.9M | -$258.0K | -$300.0K | $472.0K | $30.0K | -$371.0K | ||||||||||||||||||||||||||||||||||||
| Depreciation And Amortization | $421.0K | $514.0K | $652.0K | $637.0K | $648.0K | $634.0K | $626.0K | $704.0K | $812.0K | $811.0K | $1.7M | $2.7M | $3.4M | $3.5M | $358.0K | $5.0K | $5.0K | $4.0K | $3.0K | $1.0K | |||||||||||||||||||||||||||
| Paid In Kind Interest | $478.0K | $351.0K | $734.0K | $13.0K | $467.0K | $406.0K | $47.0K | $383.0K | -$33.0K | ||||||||||||||||||||||||||||||||||||||
| Amortization Of Financing Costs | $262.0K | $248.0K | $15.0K | $14.0K | $46.0K | $47.0K | $381.0K | $36.0K | $36.0K | $35.0K | $16.0K | ||||||||||||||||||||||||||||||||||||
| Stock Repurchased During Period Value | $1.3M | $870.0K | $867.0K | $3.2M | $950.0K | $999.0K | $963.0K | $4.6M | $531.0K | $599.0K | $903.0K | $1.0M | $62.0K | $11.0K | $53.0K | $745.0K | |||||||||||||||||||||||||||||||
| Warrants And Rights Outstanding | $101.0K | $129.0K | $127.0K | $28.0K | $35.0K | $15.0K | $36.0K | $65.0K | $197.0K | $201.0K | $187.0K | $161.0K | $189.0K | $178.0K | $467.0K | $616.0K | $586.0K | $536.0K | $316.0K | $250.0K | $288.0K | ||||||||||||||||||||||||||
| Marketable Investment Principal Payment | $7.0K | $10.0K | $13.0K | $18.0K | $18.0K | $21.0K | $19.0K | $24.0K | |||||||||||||||||||||||||||||||||||||||
| Interest And Other Income | -$711.0K | -$2.0K | -$34.0K | -$133.0K | $15.0K | $23.0K | $44.0K | $45.0K | $45.0K | $69.0K | $69.0K | $85.0K | $147.0K | $49.0K | |||||||||||||||||||||||||||||||||
| Investment Income Interest | $92.0K | $88.0K | $88.0K | $90.0K | $91.0K | $87.0K | $91.0K | $79.0K |
Most recent annual filing with the SEC: March 20, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.